Table 3.
Hazard-Ratio | p | |
---|---|---|
LVGFI | 0.938 (0.887–0.991) | 0.023 |
Older age at implantation | 1.060 (1.014–1.107) | 0.010 |
LVEF (MRI) | 1.021 (0.926–1.124) | 0.673 |
LVEF (Echo) | 0.984 (0.930–1.041) | 0.876 |
NYHA ≥ II | 0.488 (0.129–1.841) | 0.483 |
presence of diabetes | 0.714 (0.194–2.622) | 0.384 |
diuretic usage | 1.476 (0.426–5.119) | 0.331 |
Spironolactone usage | 0.513 (0.183–1.438) | 0.271 |
Amiodaron or Sotalol usage | 4.081 (0.518–32.149) | 0.150 |
Female sex | 0.414 (0.150–1.139) | 0.087 |